LOS ANGELES--(BUSINESS WIRE)--HemaCare Corporation, a leader in cell and tissue collection, processing and cell therapy solutions, today announced a two-year, multi-event sponsorship of the Phacilitate Cell & Gene Therapy Forums. Considered the largest gathering of cell and gene therapy experts in the world, Cell & Gene Therapy Forums draw leaders from the pharma and biotech communities interested in the latest innovations in cell therapy.
“As we continue our rapid expansion into the cell therapy space, we have noticed growing interest from our clients as well as prospective partners looking for ways to mitigate the variability of working with human cells to achieve the best possible research outcomes,” said Pete van der Wal, HemaCare’s Chief Executive Officer. “Our reputation for exceeding our customers’ expectations by supplying human cells with consistently high purity and viability is a testament to our expertise in GMP/GTP-compliant cell collection, handling and logistics. We look forward to learning from our clients and collaborators attending the conference regarding how HemaCare can further assist them with their research, process development, clinical trials, and commercialization needs.”
In addition to its sponsorship, HemaCare will participate in a panel discussion on raw material sourcing and regulatory requirements during Cell & Gene Therapy Europe in Barcelona.
Date/Time: Tues., Sept. 29, 2015, 12:00-3:55 p.m.
Title: Enabling allogeneic cell therapy product and supply chain development in Europe
3:10 p.m. – Cryopreserved Leukopaks Maintain Cell Viability and
Functionality: A Solution for Cell Therapy Logistics
- Louis Juliano, Senior Vice President, Global Sales & Business Development, HemaCare Corporation
Since 1978, HemaCare Bioresearch Products & Services has been the trusted research partner of choice from concept to commercialization. Built on a 37-year history in apheresis collection, HemaCare is a leader in Cell and Tissue Collection, Processing and Cell Therapy, providing the high-quality biological material needed to ensure quality research outcomes that meet the unique needs of the scientific community. For more information please visit www.hemacare.com.